GSK says tests indicate antibody drug works against Omicron – Reuters

Dec 2 (Reuters) – Laboratory analysis of the antibody-based COVID-19 therapy GlaxoSmithKline (GSK.L) (GSK) is developing with U.S. partner Vir (VIR.O) has indicated the drug is effective against the … [+1873 chars]